UTX, ST Aerospace Ink Service Agreement

Posted on by

UTC Aerospace Systems, a division of United Technologies Corp. (UTX), recently signed a long-term service agreement with ST Aerospace for Boeing 787 fleet. The license agreement entails ST Aerospace to provide maintenance, repair and overhaul (MRO) services to UTC Aerospace Systems while developing components for the Boeing 787 aircraft.

ST Aerospace (Singapore Technologies Aerospace Ltd) is the largest commercial airframe MRO provider. It is the aerospace arm of ST Engineering, an integrated engineering group providing solutions and services for aerospace, electronics, land systems and marine sectors. ST Aerospaces customer base includes advanced military forces, major airlines and leading freight carriers.

Under this agreement, ST Aerospace will provide reliable nose-to-tail maintenance solutions for UTC Aerospace Systems components installed on the Boeing 787. With the prevailing competitive environment in the aviation industry, UTC Aerospace primarily aims to build long-term customer relationship and this agreement is a further initiative in this regard. Moving forward, ST Aerospace aims to provide adaptive maintenance solutions to Boeing 787 operators to offer long-term value to its customers.

Based in Hartford, Conn., United Technologies provides high-end technology products and services to the building systems and aerospace industries worldwide. The company is a diversified business conglomerate serving various end markets such as aerospace, defense and commercial construction. The business diversification allows the company to remain profitable during tough economic times.

The operations of the company are primarily classified into two principal businesses: commercial and aerospace. The aerospace business of the company consists of Sikorsky aircraft and the UTC Propulsion & Aerospace Systems, which includes UTC Aerospace Systems and Pratt & Whitney divisions. In the last reported quarter, UTC Aerospace systems sales was $3,263 million compared with $1,236 million in the year-ago quarter. UTX currently has a Zacks Rank #3 (Hold). Other stocks that look promising and are worth a look now in the industry include Compass Diversified Holdings (CODI), Hutchison Whampoa Ltd (HUWHY) and ITT Corporation (ITT), each carrying a Zacks Rank #2 (Buy).

Read the Full Research Report on UTX

Read the Full Research Report on HUWHY

Read the Full Research Report on CODI

Zacks Investment Research

Here is the original post:

UTX, ST Aerospace Ink Service Agreement

PPG Aerospace Donates Advanced Coatings System for Restoring Mystere 20 Jet

Posted on by

LE BOURGET AIRPORT, France--(BUSINESS WIRE)--

PPG Industries (PPG) aerospace business donated the latest-technology DESOTHANE(R) HD basecoat/clearcoat for repainting the first Dassault Mystere 20 production aircraft, which was restored for the 50th anniversary celebration of its first flight.

The restored Mystere 20 business jet with serial number 1 will be on display on Le Bourget Airports tarmac, in front of the Advanced Air Support facility, through June 23, after which it returns to Frances air and space museum, Musee de lAir et de lEspace, at Le Bourget Airport for permanent display.

According to Gilles Brosseau, PPG sales manager, South Europe, maintenance, repair and overhaul, and Herve Matthys, PPG sales manager, South Europe, original-equipment manufacturers, PPG provided Desothane HD/CA 9008 basecoat/clearcoat because of its aesthetic, application, performance and environmental benefits.

For the best business jet of its age, PPG Aerospace offered its best technology of today with brand-new Desothane HD/CA 9008 basecoat/clearcoat, Brosseau said. The painters applied it on a very tight schedule and said they especially appreciated the short cycle time allowed by this scheme, with an astounding appearance and gloss for both solid and metallic colors. We wanted the Mystere 20 to look good today and for years to come.

The aircraft was painted white, red, blue and black with silver metallic wings and belly to recreate the flight-test livery, then clear-coated for enhanced durability and increased color and gloss retention.

STTS Group, Europes largest specialist aerospace painting and sealing company, repainted the Mystere 20 jet at its Le Bourget facility after restoration by IT Mercure, a nonprofit aircraft restoration association. PPGs technical service team in Gonfreville, France, worked with Dassault, STTS and IT Mercure.

PPG has assisted IT Mercure and Dassault on other aircraft restorations, including a Mercure regional jet and several fighter aircraft such as a Mirage 4000, Mirage III and Mystere II, Matthys said, adding that PPG was glad to be part of this team that benefitted from the professional painting expertise of STTS.

High-solids, chromate-free Desothane HD/CA 9008 basecoat/clearcoat consists of a heavily pigmented basecoat that provides color in one coat, instead of the typical two or three coats, saving material and application time. The clearcoat provides extended service life, improved buffability and a smoother surface that is easier to clean.

Brosseau said that Desothane HD/CA 9008 basecoat/clearcoat also can be used as part of a completely chromate-free exterior system qualified to SAE Internationals Aerospace Material Specification 3095A.

View original post here:

PPG Aerospace Donates Advanced Coatings System for Restoring Mystere 20 Jet

Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota …

Posted on by

Sarasota, Florida (PRWEB) June 18, 2013

After almost 20 years of performing regenerative treatments in the field of non surgical orthopedics, Wellington Chen, M.D., will begin conducting clinical trials for many degenerative diseases using adipose-derived stem cell therapy in Sarasota, Florida. The independent review board of the International cell medicine society is responsible for overseeing these trials.

Advanced Rejuvenation will treat patients suffering from chronic obstructive pulmonary disease (COPD) and osteoarthritis following the IRB-approved protocols. Advanced Rejuvenation will be using adult autologous stem cells, harvested from the patients own adipose (fat) tissue or bone marrow if fat is not available. Because patients are receiving their own cells, there is no risk of rejection. As of 2007, over 9,000 studies have shown the safety using these cell lines.

Autologous stem cell therapy are your bodies repair men. They are circulated throughout your body and as soon as there is a need for them, chemical messages trigger them to migrate to the area and do their magic. They are both immune modulating and also regenerative which makes them a great therapeutic agent for osteoarthritis and COPD. Numerous studies have shown them to have the capacity to grow new cartilage, muscle, ligaments, glands and even organs. We believe stem cell treatments will become the future of care for most orthopedic problems avoiding the need for surgery. With COPD, when stem cells are run into the blood stream through an IV they will mostly pass through the lungs. We are excited to be apart of these research studies.

Advanced Rejuvenation trained under scientist Kristin Comella, CEO of Stemlogix. She was recently named in the Wall Street Journal as one of the 50 most influential people on stem cell research. Advanced Rejuvenation will implement Stemlogixs patented extraction process, allowing for an exceptionally high yield and viability of stem cells from fat.

During the in-office and same day procedure, a mini liposuction is performed. A half of a cup of fat in harvested from around the abdominal region which produces approximately 8 million stem cells. The stem cells are isolated put back into the patients joints or with COPD via an IV infusion. Local anesthesia is all that is needed and pain medication can be prescribed but is rarely necessary.

Advanced Rejuvenation has treated various orthopedic conditions for 4 years using fat transfer and now offers these treatments to patients ranging from NFL players to retired golfers. If you would like more information, e-mail Advanced Rejuveantion at AskDrGecko(at)Gmail(dot)com or call our office.

About Advanced Rejuvenation

Advanced Rejuvenation is a multi specialty practice in Sarasota, Florida, specializing in regenerative treatments such as Stem Cell Treatments, Prolotherapy, Ozone Therapy, Naturopathic, Acupuncture, Chiropractic Functional Neurology, Osteopathy, Functional Medicine, Active Isolated Stretching (AIS)

Contact: Advanced Rejuvenation Phone: (941) 330-8553 E-mail: AskDrGecko(at)Gmail(dot)com Website: http://www.SarasotaStemCell.com Office address: 2033 Wood Street #210 Sarasota, Florida 34237

Read the rest here:
Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota ...

A lab love connection

Posted on by

When it came time to take their wedding photos, FuiBoon Kai and Andrew Leidal knew that one location had to be on their list: the Microbiology labs in which they met.

Kai, who just graduated with her PhD in Microbiology from Dal, met her future husband while working in side-by-side labs.

She was having trouble a technique in her lab and I made excuses to try and assist her with what she was doing, says Leidal. My motives werent just to help with the science, he jokes.

Leidal grew up on a farm in southern Ontario. He completed his undergrad at the University of Toronto before coming to Dal to study viruses and cancers. Kai is from Malaysia and does research on prostate cancer.

When it came to the proposal wedding proposal, that is, not a research one Kai admits to being a little difficult.Leidal first had the impulse to propose when he spotted a massive rainbow near the Bedford Basin after a major storm. She would say, Havent you seen a storm before? I want to go home and do my work. When Leidal planned on proposing with breakfast in bed, Kai was more worried about getting crumbs on the sheets until he pointed out there was something else on the tray. He then got down on one knee and popped the question.

The couple had two weddings: one in Malaysia and one in Canada. The Malaysian wedding was first. It consisted of many traditions and had 700 guests, including Leidals family and friends from the lab. There was a traditional Chinese ceremony which involved Leidal paying a dowry, which included a roasted pig. In a traditional Chinese wedding, the members of the brides immediate family are given their invitations by hand from the groom with a slice of the roasted pork and a slice of cake. The brides family get the choice cuts of the pig and the grooms family get the butt and the head.

The Canadian wedding was a traditional Catholic wedding held at the St. Thomas Aquinas Church on Oxford street with a reception at the Lord Nelson. The brides immediate family came from Malaysia and everyone from the lab attended the wedding. All of the bridesmaids and groomsmen were members of the labs. With the exception of immediate family, everyone there was from lab, says Leidal. And, of course, there were photos taken in the lab as well.

The bride and groom both come from very different backgrounds, but have found common ground here at Dalhousie.

Were both very thankful to have come to Dal and met each other. Its really destiny that weve met, says Kai.

More:
A lab love connection

New virus discovered in patients with central nervous system infections

Posted on by

Public release date: 18-Jun-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

Patients in Vietnam and other locations with central nervous system infections may well be suffering from the effects of a newly discovered virus, according to a study to be published in mBio, the online open-access journal of the American Society for Microbiology. Researchers have detected the virus in spinal fluid from 4 percent of 642 patients with central nervous system infections of unknown cause, and in an average of 58 percent of fecal samples from pigs and poultry, suggesting animals may serve as reservoirs for transmission to humans. The virus, called CyCV-VN, belongs to the Cyclovirus genus, a group that has never before been implicated in human or animal disease.

"The detection of CyCV-VN in a usually sterile material like cerebrospinal fluid is remarkable and may point to a pathogenic role of this virus as a single or a co-infecting pathogen," says corresponding author Tan Le Van of the Oxford University Clinical Research Unit in Ho Chi Minh City, Vietnam. The results in this study, Van cautions, do not provide absolute proof of disease causation, and further work is needed to see whether the virus poses a threat to human and animal health.

Acute central nervous system infections are responsible for illnesses and deaths around the world, but they are a particular problem in tropical regions. These infections can be caused by any of a number of bacterial, parasitic, fungal or viral pathogens, but the majority of cases go undiagnosed despite extensive efforts to identify a cause. "One of our particular interests is to improve patient diagnosis," says Van. Proper diagnosis "is essential to improve clinical management and prevention of these devastating diseases, he continues.

Inspired by the high incidence of acute central nervous system infections in Vietnam, Van and his colleagues set out to identify previously uncharacterized viruses in undiagnosed patients. Using fluid samples from more than 1,700 patients with suspected central nervous system infections or suspected viral encephalitis, the researchers generated 161,000 DNA sequence reads for further analysis.

Among these thousands of sequences, the researchers identified a sequence from a member of the Cyclovirus genus that was present in two patients, one adult and one child, both with acute central nervous system infections of unknown cause. Follow-up work with a technique called inverse PCR used that short sequence to determine the entire genome sequence of the virus present in one of the samples. CyCV-VN is a unique new species of Cyclovirus, a group that includes no known pathogens.

With the full genome in hand, the researchers went back to 642 samples from patients with suspected acute central nervous system infections and were able to detect the virus in samples from 26 patients (4 percent). The virus was not detected at all in samples from patients with non-infectious conditions of the central nervous system, like multiple sclerosis, a fact that argues that the virus could well be a human pathogen.

The virus was also detected in samples from farm animals in the province where the index patient lived: between 42 percent and 100 percent of fecal samples from pigs, ducks, and chickens in that region harbored viruses that are extremely closely related to CyCV-VN. This raises the possibility - but not certainty - say the authors, that livestock could represent a source for human infection with the virus.

Van also cautions that it is too soon to point an accusing finger at CyCV-VN. "Detection of a virus in human samples alone is insufficient to provide a direct link with an ongoing infection," he says. "Addressing the question of causation requires extensive effort."

Here is the original post:
New virus discovered in patients with central nervous system infections

Research and Markets: Vitro Diagnostics in Canadian Market Forecast to 2018- Clinical Chemistry Genetic Testing …

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/qrxghc/canada_in_vitro) has announced the addition of the "Canada In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" report to their offering.

"Vitro Diagnostics in Canadian Market Forecast to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture", provides key market data on the Canada In Vitro Diagnostics market.

The report provides value (USD million) data for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This research is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.

Key Topics Covered:

1. List of Tables and List of Figures

2. Introduction

3. In Vitro Diagnostics in Canada

4. Clinical Chemistry in Canada

See the article here:
Research and Markets: Vitro Diagnostics in Canadian Market Forecast to 2018- Clinical Chemistry Genetic Testing ...

The American Society for Microbiology honors Joshua Obar

Posted on by

Public release date: 18-Jun-2013 [ | E-mail | Share ]

Contact: Garth Hogan ghogan@asmusa.org 202-942-9389 American Society for Microbiology

Washington, D.C. June 18, 2013 Joshua Obar, Ph.D., Department of Immunology and Infectious Diseases, Montana State UniversityBozeman, has been honored with a 2013 ICAAC Young Investigator Award for his research on factors affecting the regulation of immunological memory responses to infection.

Obar earned his B.A. in Microbiology from Ohio Wesleyan University in 2001 and went on to complete his Ph.D. in Microbiology and Immunology from Dartmouth College in 2006. He performed his Ph.D. thesis research in Edward Usherwood's laboratory at the Geisel School of Medicine at Dartmouth, where his graduate work focused on understanding how latent viral infections affect the formation, maintenance, and function of memory CD8 T cells. Of Obar, Usherwood says, "I have encountered very few young scientists at his level who have such a depth of perception into their chosen field, combined with the intellectual drive and rigor to pursue projects through to completion." In 2005, his graduate work was recognized by the American Association of Immunologists (AAI) with the Huang Foundation Trainee Achievement Award (now the Life Technologies Trainee Achievement Award). The following year Obar joined Leo Lefranois' laboratory at the University of Connecticut Health Center as a postdoctoral fellow, where he received a NRSA postdoctoral fellowship in 2007. During his postdoctoral research he developed the methodology necessary to quantify the number of antigen-specific nave CD8 T cells within a polyclonal population, which he used to study early events regulating effector and memory CD8 T cell development during numerous infectious diseases.

In 2010, Obar joined the faculty in the Department of Immunology and Infectious Diseases at Montana State University Bozeman. Since starting his own laboratory he has been studying the innate immune response in the respiratory tract following viral and fungal infections by trying to understand what regulates the balance of immunity and immunopathology during these infections. Obar's nominator and Chair of his department at Montana State University, Mark Quinn, said "since coming to Montana State University, Josh has continued to excel in his research on understanding the role of T cells and other leukocytes in the immune response to viral pathogens." In addition to the Huang Foundation Trainee Achievement Award, Obar has also won a NIH K22 Award and in 2012, he was selected by the AAI Public Policy Fellowship Program. Quinn concludes by saying, "Overall, Obar is an outstanding young investigator with amazing potential for a stellar career in microbiology and infectious diseases."

###

The ICAAC Young Investigator Award will be presented during ASM's 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 10-13, 2013 in Denver, Colorado. ASM is the world's oldest and largest life science organization and has more than 40,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health, economic, and environmental well-being.

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Link:
The American Society for Microbiology honors Joshua Obar

Cosmetic Surgeon Dr. William Middleton Claims the Vampire Stem Cells Facial as an Exceptional Anti-Aging Solution

Posted on by

Toronto, Canada (PRWEB) June 18, 2013

According to Stanford Medical, platelet-rich plasma has been used in applications of medicine for decades. Now, doctors have developed the vampire facial, utilizing platelet- rich plasma, delivering a revolutionary organic anti-aging procedure.

Platelet-rich plasma therapy, better known as PRP, has been used by doctors for years to treat and help heal injuries and conditions related to muscles, bones, and tendons. More recently however, doctors have been implementing PRP in their evolving quest to find treatments to fight against the signs of aging. PRP facial, or more commonly referred to as the vampire facial, has shortly become Hollywoods latest trend, attracting celebrities like Kim Kardashian and even being featured in this years Academy Awards gift bags. Though relatively new and not well studied, PRP and the vampire facial just might be the next great breakthrough in anti-aging treatments.

PRP, the active ingredient of the vampire facial, was originally developed to aid in healing injuries and conditions, most commonly, sports injuries such as torn ACLs. PRP helps athletes recover faster by promoting and speeding up the heeling process. As Stanford Medical described it, The basic idea behind PRP injection is to deliver high concentrations of growth factors to an area of injury, with hope of stimulating a healing response and reducing inflammation in the tissue. The same idea applies to reducing the signs of aging.

When undergoing a vampire facial, doctors draw blood from the patients arm and then spin the blood in a centrifuge, separating it into its different parts of red blood cells, platelets, and plasma. The middle layer, composed of PRP, contains highly concentrated platelets, which are the cells that normally promote clotting. These platelet cells consist of a number of specialized cells called growth factors. When injected, these growth factor cells interact with local skin cells and send signals. These signals ultimately initiate a variety of events including cell division, migration, and collagen formation. The idea is that by promoting the formation of collagen, the primarily ingredient that has been linked to helping correct the visible effects of wrinkles, the body is rejuvenating itself.

When reading it from a textbook, the science makes sense, however there is still a lot that is fairly unknown in regards to the vampire facial. As Popular Science states, Theres no evidence at all that this gory procedure works, and only the babiest starting evidence that injecting platelets into the skin works at all against the appearance of aging. Needless to say, this isnt stopping many people. Since the vampire facial is 100% organic, all-natural, and derived from your own blood, there are few side affects and no chance of an allergic reaction. Furthermore, a vampire facial does not use any additional chemically engineered injectables such as Botox or dermal fillers, which have a greater chance of causing an allergic reaction and side affects.

The vampire stem cell facial has lately been receiving a lot of attention in all the major fashion and pop culture magazines, and from of the looks of it, this procedure really works. In a recent issue of Glow Magazine, the senior editor, Katie Rae, decided to try out this hot new procedure. She consulted with Dr. Middleton, a premier cosmetic surgeon in Toronto, for her vampire facial. After undergoing the vampire facial with Dr. Middleton, in Katie Raes article she reported, I do look fresher and more rested. My face looks fuller and calmer somehow. Katie Rae further writes, I go to the mirror and I am pleasantly surprised at what I see. The next day, a co-worker tells me I look 5 years younger.

With results like those seen with Katie Rae, the vampire facial is likely to grow and become apart of our anti-aging regimen. Dr. Middleton is just one of a handful of qualified cosmetic surgeons that understand the benefits of the vampire facial and are offering it to their patients. The vampire facial is giving those seeking anti-aging treatments another option to choose from.

Original post:
Cosmetic Surgeon Dr. William Middleton Claims the Vampire Stem Cells Facial as an Exceptional Anti-Aging Solution

Premier Anti-Aging Company Ageology Expands Network with New Associate Dr. Galen Eversole

Posted on by

CHICAGO, June 18, 2013 /PRNewswire/ --Ageology, http://www.ageology.com, a premier anti-aging medicine company, today announced that Dr. Galen Eversole has joined the Ageology network. Helping patients regain and maintain optimum health and address the challenges associated with normal signs of aging is the purpose that unites Ageology and Eversole. The addition of Galen and his practice to the network expands Ageology's corporate presence into Nevada for the first time.

"I am excited about the opportunity to work with Dr. Savage and join a team that is committed to anti-aging medicine," said Dr. Eversole. "It is very rewarding to help people who are striving to live lives of quality as they age, but facing challenges that make such quality feel unattainable at times. Our goal is to help them change that dynamic and feel better about how they achieve it."

Dr. Eversoleis a fellow of the American Academy ofAnti-aging Medicine, a member of the Age Management Medicine Group and is certified in medical aesthetics. He is a supporting member of the American Academy of Family Practice, is board-certified in anatomic and clinical pathology and cytopathology through the American Board of Pathology and in Molecular Diagnostics through the American Board of Clinical Chemistry. Dr. Eversole, driven by his concerns over the obesity epidemic and the rise in chronic and degenerative diseases, is passionate about direct patient care and his desire to have an impact one life at a time. He completed his undergraduate degree cum laude at Wabash College in Crawfordsville, IN. He graduated from the University of New Mexico School of Medicine and did his pathology residency at UNM in Albuquerque, NM. He earned his MBA at the University of South Florida in Tampa.He is committed to helping his patients chart and navigate a new course in their health through lifestyle modifications to reduce the risks of developing chronic diseases of aging.

"Ageology is extremely pleased to have a physician of Galen's caliber join the Ageology network," said Dr. Paul Savage, founder of Ageology, CEO and Chief Medical Director, and one of the nation's premier anti-aging physicians. "His commitment to the practice of aging medicine, and the individualized approach required to drive results for patients is the embodiment of our vision for Ageology."

About AgeologyAgeology is focused on the application of integrative healthy aging medical practices that help people regain and maintain their optimal health despite the changes that occur as they age. The core treatment paradigm involves medical evaluation, nutrition and wellness guidance as well as hormone and supplement therapy. Headquartered in Chicago, the company is built around a growing national network of integrative anti-aging physicians and experts, but is primarily driven by the vision of its founder, Dr. Paul Savage.

About Dr. Paul Savage Dr. Paul Savage MD FACEPis a world-renowned physician and acknowledged expert in the field integrative healthy aging, regenerative and metabolic medicine. Dr. Savage is board-certified by the American Academy of Anti-Aging Medicine (A4M), as well as, a Fellow of Anti-Aging and Regenerative Medicine. He has been practicing anti-aging medicine since 2002. His goal for his patients is to regain and maintain optimum health as the best method for preventing disease. He remains on the front lines of integrative medicine therapies and continues to treat patients personally.

Media Contact:

Lisa Spathis Email 847 831 1367

This press release was issued through eReleases Press Release Distribution. For more information, visit http://www.ereleases.com.

Go here to read the rest:
Premier Anti-Aging Company Ageology Expands Network with New Associate Dr. Galen Eversole

Research and Markets: Thermo Fisher Scientific, Inc. Market Share Analysis – 2013 Report Out Now

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/6h74b7/thermo_fisher) has announced the addition of the "Thermo Fisher Scientific, Inc. Market Share Analysis" company profile to their offering.

The new report, Thermo Fisher Scientific, Inc. Market Share Analysis provides in-depth information on Thermo Fisher Scientific, Inc.'s market position in the different medical equipment markets it operates in. The report provides Thermo Fisher Scientific, Inc. market share information in five key market categories - Infectious Immunology, Microbiology Culture, Immuno Chemistry, Clinical Chemistry and Histology And Cytology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

Scope

- Global company shares (in Revenues) information for the key markets Thermo Fisher Scientific, Inc. operates in - In Vitro Diagnostics

- Thermo Fisher Scientific, Inc.'s company shares (in Revenues) information for all the key countries the company has presence in - Brazil, Japan, Germany, France, Canada, United Kingdom, Spain, Italy, United States, Australia, China and India.

- Thermo Fisher Scientific, Inc.'s company shares (in Revenues) information for all the key market categories the company has presence in - Infectious Immunology, Microbiology Culture, Immuno Chemistry, Clinical Chemistry and Histology And Cytology.

- All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa.

- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in.

- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Link:
Research and Markets: Thermo Fisher Scientific, Inc. Market Share Analysis - 2013 Report Out Now

Research and Markets: Bio-Rad Laboratories, Inc. Market Share Analysis – 2013 Out Now

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/fj8w5l/biorad) has announced the addition of the "Bio-Rad Laboratories, Inc. Market Share Analysis" company profile to their offering.

The new report, Bio-Rad Laboratories, Inc. Market Share Analysis provides in-depth information on Bio-Rad Laboratories, Inc.'s market position in the different medical equipment markets it operates in. The report provides Bio-Rad Laboratories, Inc. market share information in five key market categories - Microbiology Culture, Genetic Testing, Haematology, Infectious Immunology and Immuno Chemistry. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

Scope

- Global company shares (in Revenues) information for the key markets Bio-Rad Laboratories, Inc. operates in - In Vitro Diagnostics.

- Bio-Rad Laboratories, Inc.'s company shares (in Revenues) information for all the key countries the company has presence in - Australia, India, Japan, China, France, Spain, Italy, United Kingdom, Germany, Canada, United States and Brazil.

- Bio-Rad Laboratories, Inc.'s company shares (in Revenues) information for all the key market categories the company has presence in - Microbiology Culture, Genetic Testing, Haematology, Infectious Immunology and Immuno Chemistry.

- All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia-Pacific, South and Central America and Middle East and Africa.

- Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.

- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in..

See the original post here:
Research and Markets: Bio-Rad Laboratories, Inc. Market Share Analysis - 2013 Out Now

Premier Anti-Aging Company Ageology Expands Network with Ohio-Based Associate Dr. John Kocka

Posted on by

CHICAGO, June 17, 2013 /PRNewswire/ --Ageology, http://www.ageology.com, a premier anti-aging medicine company, today announced that Dr. John Kocka has joined the Ageology network. Helping patients regain and maintain optimum health and address the challenges associated with normal signs of aging is the purpose that unites Ageology and Kocka. The addition of Kocka and his practice to the network expands Ageology's corporate presence into Ohio for the first time.

"I am excited about the opportunity to work with Dr. Savage and join a team that is committed to anti-aging medicine," said Dr. Kocka."It is very rewarding to help people who are striving to live lives of quality as they age, but facing challenges that make such quality feel unattainable at times. Our goal is to help them change that dynamic and feel better about how they achieve it."

Dr. Kocka is board-certified in Anti-Aging Medicine, Family Medicine and Preventive Medicine and has practiced age management medicine for over 10 years. He is passionate about weight training, functional training, exercise, nutrition, and wellness and the impact it can have for his patients to achieve optimal health and function, improving the quality of their lives. He trained at the Cleveland Clinic, completing his residency in Family Medicine with special interest in preventive and sports medicine and graduated from the Medical University of Ohio and graduated Valedictorian of his class at the University of Toledo Honors Program. He is committed to practicing good preventative medicine for better health and optimal function to live strong.

"Ageology is extremely pleased to have a physician of Dr. Kocka's caliber join the Ageology network," said Dr. Paul Savage, founder of Ageology, CEO and Chief Medical Director, and one of the nation's premier anti-aging physicians."John's commitment to the practice of aging medicine, and the individualized approach required to drive results for patients is the embodiment of our vision for Ageology."

About Ageology

Ageology is focused on the application of integrative healthy aging medical practices that help people regain and maintain their optimal health despite the changes that occur as they age. The core treatment paradigm involves medical evaluation, nutrition and wellness guidance as well as hormone and supplement therapy. Headquartered in Chicago, the company is built around a growing national network of integrative anti-aging physicians and experts but is primarily driven by the vision of its founder, Dr. Paul Savage.

About Dr. Paul Savage

Dr. Paul Savage MD FACEPis a world-renowned physician and acknowledged expert in the field integrative healthy aging, regenerative and metabolic medicine. Dr. Savage is board-certified by the American Academy of Anti-Aging Medicine (A4M), as well as, a Fellow of Anti-Aging and Regenerative Medicine. He has been practicing anti-aging medicine since 2002. His goal for his patients is to regain and maintain optimum health as the best method for preventing disease. He remains on the front lines of integrative medicine therapies and continues to treat patients personally.

Media contact: Lisa Spathis Email 847 831 1367

This press release was issued through eReleases Press Release Distribution. For more information, visit http://www.ereleases.com.

Read more:
Premier Anti-Aging Company Ageology Expands Network with Ohio-Based Associate Dr. John Kocka

Cargo Craft Makes a "Relatively" Large Delivery to The International Space Station – Video

Posted on by


Cargo Craft Makes a "Relatively" Large Delivery to The International Space Station
The European Space Agency #39;s "Albert Einstein" Automated Transfer Vehicle (ATV) arrived at the International Space Station June 15, automatically docking to t...

By: NASAtelevision

View original post here:

Cargo Craft Makes a "Relatively" Large Delivery to The International Space Station - Video

Part of Space Station Found

Posted on by

Phil Green holds a piece of the Mir space station that he discovered along the Merrimack River six years ago.CBS Boston

Next time you go fishing, don't be surprised if you catch more than just a fish.

A Massachusetts man was walking along the Merrimack River when a strange-looking rock caught his attention.

"There she was just sitting there, sticking up like that, and I said heck what is this," Phil Green told CBS Boston. "It just didn't belong."

Green knew there was something different about the greenish rock he discovered but it took him six years to contact a friend who worked for NASA to further investigate.

NASA confirmed that Green's "rock" was actually a small piece of the Russian space station Mir.

Mir went up to space in 1986 and returned to earth in 2001. It is unclear how many rogue pieces of Mir exist, butmost of the space station landed in the South Pacific.

A custodian at Amesbury Elementary School, Green brought in the piece for show and tell.

"I had a lot of fun taking it to school and showing it to all the kids," he said.

The "rock" is Green's most prized possession and sits in his house alongside a letter from NASA.

The rest is here:

Part of Space Station Found

European Cargo Ship ‘Albert Einstein’ Docks at Space Station

Posted on by

PARIS Europe's fourth Automated Transfer Vehicle pulled into port at the International Space Station on Saturday (June 15), delivering a hefty load of supplies, including rocket fuel, experiments, food and clothing for the lab's six-person crew.

The 20-ton spaceship, named for physicist Albert Einstein, docked with the space station's Russian service module at 10:07 a.m. EDT (1407 GMT) after a glacial automated approach guided by high-tech lasers and cameras.

The docking occurred about 20 minutes behind schedule after engineers at the ATV control center in Toulouse, France, took extra time to reset navigation parameters on the unmanned supply craft. [See Photos of Europe's ATV Robotic Space Cargo Ships]

"Thanks to the ground teams," Italian astronaut Luca Parmitano posted on his Twitter account. "ATV docking was really easy. Now the hard job begins: unpacking everything!"

The cargo ship blasted off on an Ariane 5 rocket from French Guiana on June 5, beginning a 10-day pursuit of the space station. A Russian Progress supply freighter left the space station Tuesday, clearing the aft port of the Zvezda service module for the arrival of the Albert Einstein spacecraft.

The ATV hauled seven tons of payload to the space station, including 5,465 pounds (2,479 kilograms) of supplies stowed inside the craft's cargo cabin. The materials include food tiramisu, lasagna, parmesan and other meals along with experiments, clothing and spare parts.

"With the fourth ATV now ready to support and supply the space station with essential supplies and scientific experiments, ESA again proves itself to be a reliable partner in the international station upon which the future can be developed," said Jean-Jacques Dordain, director general of the European Space Agency.

Astronauts will open the hatches between Zvezda and the cargo ship Monday, with unpacking of the ATV's pressurized compartment due to begin Tuesday. Technicians loaded the ATV's cargo hold with 209 bags containing 1,400 items, which will take several weeks for the crew to move and store inside the space station.

Most of the supplies are for NASA, which uses resupply craft owned by Europe and Japan in a barter arrangement. The European Space Agency and Japan Aerospace Exploration Agency pay for their share of the space station's operating costs through cargo services instead of cash.

ESA says each ATV mission costs 450 million euros, or about $600 million.

Originally posted here:

European Cargo Ship 'Albert Einstein' Docks at Space Station